AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease

被引:97
作者
Dorer, Russell [1 ]
Odze, Robert D. [1 ]
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
AMACR; Barrett's esophagus; dysplasia; pathology; ulcerative colitis; Crohn's disease;
D O I
10.1097/01.pas.0000213268.30468.b4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
alpha-Methylacyl-CoA racemase (AMACR) catalyzes the racemization of alpha-methyl, branched carboxylic coenzyme A thioesters, and is overexpressed in a variety of neoplasms, such as prostate and colon cancer. The aim of this study was to evaluate AMACR expression in the metaplasia-dysplasiacarcinoma sequence in Barrett's esophagus (BE), ulcerative colitis (UC), and Crohn's disease (CD) and to determine whether its expression can be used to detect dysplastic epithelium in these conditions. One hundred thirty-four routinely processed biopsy and/or resection specimens from 134 patients with BE [M/F ratio: 5.7, mean age: 67y (36 negative (intestinal metaplasia only), 14 indefinite for dysplasia (IND), 16 low-grade dysplasia (LGD), 32 high-grade dysplasia (HGD), and 36 invasive adenocarcinoma (ACA)] and 74 specimens from 74 patients with inflammatory bowel disease (IBD) [56 with ulcerative colitis, 18 with Crohn's disease, M/F ratio: 1.8, mean age: 55 y (17 negative, 7 IND, 26 LGD, 10 HGD, and 14 ACA)] were immunostained with a monoclonal AMACR antibody (p504S). The degree of cytoplasmic staining in all cases was evaluated in a blinded fashion according to the following grading system: 0, negative (0% cells positive); 1 +, 1% to 10% cells positive; 2 +, 10% to 50% cells positive; or 3 +, > 50% cells positive. In patients with BE, AMACR was not expressed in any negative foci (0%) but was significantly increased (P < 0.0001) in foci of LGD (38%), HGD (81%), and ACA (72%). Three of 14 (21%) IND foci from 3 BE patients were only focally positive (grade 1: 7%, 2: 14%). However, 1 of these 3 patients had follow-up information available and had developed ACA subsequently. Similarly, in patients with IBD, AMACR was not expressed in any foci considered negative for dysplasia, but was significantly increased (P < 0.0001) in foci of LGD (96%), HGD (80%), and ACA (71%). Only 1/7 (14%) IND focus from 1 patient was focally positive (grade 1). The sensitivity for the detection of LGD and HGD in BE and IBD was 38% and 81%, and 96% and 80%, respectively, for the 2 types of disorders. The specificity was 100% for both BE and IBD. AMACR is involved in the neoplastic progression in BE and IBD. The high degree of specificity of AMACR for dysplasia/carcinoma in BE and IBD suggests that it may be useful to detect neoplastic epithelium in these conditions.
引用
收藏
页码:871 / 877
页数:7
相关论文
共 45 条
[1]  
Amery L, 2000, J LIPID RES, V41, P1752
[2]   SUCRASE-ISOMALTASE EXPRESSION IN CHRONIC ULCERATIVE-COLITIS AND DYSPLASIA [J].
ANDREWS, CW ;
OHARA, CJ ;
GOLDMAN, H ;
MERCURIO, AM ;
SILVERMAN, ML ;
STEELE, GD .
HUMAN PATHOLOGY, 1992, 23 (07) :774-779
[3]  
Arber N, 1996, CANCER EPIDEM BIOMAR, V5, P457
[4]  
Bailey T, 1998, AM J PATHOL, V152, P135
[5]   Prospective study of cyclin D1 overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma [J].
Bani-Hani, K ;
Martin, IG ;
Hardie, LJ ;
Mapstone, N ;
Briggs, JA ;
Forman, D ;
Wild, CP .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1316-1321
[6]   Endoscopic mapping and surrogate markers for better surveillance in Barrett esophagus - A study of 700 biopsy specimens [J].
Bhargava, P ;
Eisen, GM ;
Holterman, DA ;
Azumi, N ;
Hartmann, DP ;
Hanfelt, JJ ;
Benjamin, SB ;
Lippman, ME ;
Montgomery, EA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) :552-563
[7]   p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus [J].
Bian, YS ;
Osterheld, MC ;
Bosman, FT ;
Benhattar, J ;
Fontolliet, C .
MODERN PATHOLOGY, 2001, 14 (05) :397-403
[8]   Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens [J].
Browne, TJ ;
Hirsch, MS ;
Brodsky, G ;
Welch, WR ;
Loda, MF ;
Rubin, MA .
HUMAN PATHOLOGY, 2004, 35 (12) :1462-1468
[9]   Differential expression of α-methylacyl coenzyme A racemase in adenocarcinomas of the small and large intestines [J].
Chen, ZME ;
Ritter, JH ;
Wang, HL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (07) :890-896
[10]  
Coggi G, 1997, CANCER, V79, P425, DOI 10.1002/(SICI)1097-0142(19970201)79:3<425::AID-CNCR1>3.0.CO